SA pharmas urge Pepfar to buy more African-made HIV/Aids drugs
Call on US donor to shift 2-million antiretroviral patients to medicines made on the continent by 2030
SA pharmaceutical manufacturers have called on the US President’s Emergency Plan for Aids Relief (Pepfar) to procure more HIV/Aids medicines from African producers, arguing this will boost the continent’s drugmaking capacity and provide protection against future health security threats.
Pepfar is the world’s biggest HIV/Aids donor and is credited with saving more than 25-million lives with the more than $110bn it has provided over the past two decades to the countries hardest hit by the disease, including SA. Though Sub-Saharan Africa is home to two-thirds of the world’s HIV/Aids burden, less than 1% of the $750m spent by Pepfar each year on HIV/Aids-related commodities goes to products sourced from Africa...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.